KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Novartis Ag (NVS) Net Margin (2016 - 2025)

Historic Net Margin for Novartis Ag (NVS) over the last 17 years, with Q4 2025 value amounting to 388.65%.

  • Novartis Ag's Net Margin rose 3636700.0% to 388.65% in Q4 2025 from the same period last year, while for Dec 2025 it was 497.63%, marking a year-over-year increase of 4705200.0%. This contributed to the annual value of 25.64% for FY2025, which is 19100.0% up from last year.
  • As of Q4 2025, Novartis Ag's Net Margin stood at 388.65%, which was up 3636700.0% from 574.79% recorded in Q3 2025.
  • Over the past 5 years, Novartis Ag's Net Margin peaked at 670.78% during Q1 2025, and registered a low of 0.4% during Q2 2023.
  • Its 5-year average for Net Margin is 123.08%, with a median of 25.69% in 2024.
  • Its Net Margin has fluctuated over the past 5 years, first plummeted by -1267100bps in 2022, then surged by 6443200bps in 2025.
  • Novartis Ag's Net Margin (Quarter) stood at 128.14% in 2021, then tumbled by -99bps to 1.43% in 2022, then surged by 3482bps to 51.14% in 2023, then tumbled by -51bps to 24.98% in 2024, then surged by 1456bps to 388.65% in 2025.
  • Its last three reported values are 388.65% in Q4 2025, 574.79% for Q3 2025, and 423.06% during Q2 2025.